Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company has a collaboration agreement with Stand Up To Cancer for research testing a combination of teclistamab and daratumumab to treat a rare disease AL amyloidosis. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey. more
Time Frame | JNJ | Sector | S&P500 |
---|---|---|---|
1-Week Return | -1.8% | -2.27% | -0.57% |
1-Month Return | -4.32% | -3.96% | 1.21% |
3-Month Return | -11.42% | -9.7% | 7.57% |
6-Month Return | 0.8% | -3.37% | 11.45% |
1-Year Return | -5.89% | 3.71% | 28.48% |
3-Year Return | -12.96% | 3.8% | 29.52% |
5-Year Return | 3.71% | 39.78% | 90.66% |
10-Year Return | 41.04% | 106.91% | 203.75% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 82.06B | 82.58B | 78.74B | 79.99B | 85.16B | [{"date":"2019-12-31","value":96.36,"profit":true},{"date":"2020-12-31","value":96.98,"profit":true},{"date":"2021-12-31","value":92.46,"profit":true},{"date":"2022-12-31","value":93.93,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 27.56B | 28.43B | 23.40B | 24.60B | 26.74B | [{"date":"2019-12-31","value":96.94,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":82.32,"profit":true},{"date":"2022-12-31","value":86.52,"profit":true},{"date":"2023-12-31","value":94.06,"profit":true}] |
Gross Profit | 54.50B | 54.16B | 55.34B | 55.39B | 58.41B | [{"date":"2019-12-31","value":93.31,"profit":true},{"date":"2020-12-31","value":92.71,"profit":true},{"date":"2021-12-31","value":94.74,"profit":true},{"date":"2022-12-31","value":94.83,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 66.42% | 65.58% | 70.28% | 69.25% | 68.59% | [{"date":"2019-12-31","value":94.51,"profit":true},{"date":"2020-12-31","value":93.31,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.54,"profit":true},{"date":"2023-12-31","value":97.6,"profit":true}] |
Operating Expenses | 33.53B | 34.42B | 34.40B | 33.18B | 36.56B | [{"date":"2019-12-31","value":91.72,"profit":true},{"date":"2020-12-31","value":94.16,"profit":true},{"date":"2021-12-31","value":94.08,"profit":true},{"date":"2022-12-31","value":90.76,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 21.01B | 16.95B | 20.47B | 23.19B | 21.85B | [{"date":"2019-12-31","value":90.58,"profit":true},{"date":"2020-12-31","value":73.06,"profit":true},{"date":"2021-12-31","value":88.26,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.22,"profit":true}] |
Total Non-Operating Income/Expense | (3.64B) | (3.33B) | (1.90B) | (2.64B) | (6.30B) | [{"date":"2019-12-31","value":-364200000000,"profit":false},{"date":"2020-12-31","value":-332600000000,"profit":false},{"date":"2021-12-31","value":-189500000000,"profit":false},{"date":"2022-12-31","value":-264000000000,"profit":false},{"date":"2023-12-31","value":-630200000000,"profit":false}] |
Pre-Tax Income | 17.33B | 16.50B | 19.18B | 19.36B | 15.06B | [{"date":"2019-12-31","value":89.51,"profit":true},{"date":"2020-12-31","value":85.22,"profit":true},{"date":"2021-12-31","value":99.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":77.8,"profit":true}] |
Income Taxes | 2.21B | 1.78B | 1.38B | 2.99B | 1.74B | [{"date":"2019-12-31","value":73.9,"profit":true},{"date":"2020-12-31","value":59.65,"profit":true},{"date":"2021-12-31","value":46.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":58.08,"profit":true}] |
Income After Taxes | 15.12B | 14.71B | 17.80B | 16.37B | 13.33B | [{"date":"2019-12-31","value":84.93,"profit":true},{"date":"2020-12-31","value":82.66,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":91.96,"profit":true},{"date":"2023-12-31","value":74.86,"profit":true}] |
Income From Continuous Operations | 15.12B | 14.71B | 17.80B | 16.37B | 13.33B | [{"date":"2019-12-31","value":84.93,"profit":true},{"date":"2020-12-31","value":82.66,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":91.96,"profit":true},{"date":"2023-12-31","value":74.86,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 15.12B | 14.71B | 20.88B | 17.94B | 35.15B | [{"date":"2019-12-31","value":43.01,"profit":true},{"date":"2020-12-31","value":41.86,"profit":true},{"date":"2021-12-31","value":59.39,"profit":true},{"date":"2022-12-31","value":51.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
EPS (Diluted) | 8.68 | 8.03 | 9.80 | 10.16 | 10.43 | [{"date":"2019-12-31","value":83.22,"profit":true},{"date":"2020-12-31","value":76.99,"profit":true},{"date":"2021-12-31","value":93.96,"profit":true},{"date":"2022-12-31","value":97.41,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
JNJ | |
---|---|
Cash Ratio | 0.39 |
Current Ratio | 1.03 |
Quick Ratio | 0.79 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
JNJ | |
---|---|
ROA (LTM) | 8.40% |
ROE (LTM) | 20.89% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
JNJ | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.61 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.39 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
JNJ | |
---|---|
Trailing PE | 24.15 |
Forward PE | 13.79 |
P/S (TTM) | 4.03 |
P/B | 5.03 |
Price/FCF | 62 |
EV/R | 4.20 |
EV/Ebitda | 14.35 |
PEG | 0.87 |
Johnson & Johnson (JNJ) share price today is $146.62
Yes, Indians can buy shares of Johnson & Johnson (JNJ) on Vested. To buy Johnson & Johnson from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in JNJ stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Johnson & Johnson (JNJ) via the Vested app. You can start investing in Johnson & Johnson (JNJ) with a minimum investment of $1.
You can invest in shares of Johnson & Johnson (JNJ) via Vested in three simple steps:
The 52-week high price of Johnson & Johnson (JNJ) is $167.51. The 52-week low price of Johnson & Johnson (JNJ) is $139.79.
The price-to-earnings (P/E) ratio of Johnson & Johnson (JNJ) is 24.2119
The price-to-book (P/B) ratio of Johnson & Johnson (JNJ) is 5.03
The dividend yield of Johnson & Johnson (JNJ) is 3.38%
The market capitalization of Johnson & Johnson (JNJ) is $353.05B
The stock symbol (or ticker) of Johnson & Johnson is JNJ